This is an early safety study testing a new device called ENC-201-CED. It is designed to protect insulin-producing cells (islets) after they are transplanted under the skin in people with Type 1 diabetes. The main goal is to see if the device is safe and well-tolerated in 10 part…
Phase: PHASE1 • Sponsor: Encellin • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC